Breech Delivery: Vaginal vs. Cesarean — Evidence-Based Decision Making
Breech presentation (3-4% of term pregnancies) presents a complex delivery decision. The 2000 Term Breech Trial favored planned cesarean, but subsequent evidence supports selective vaginal breech delivery (VBD) in appropriate candidates.
Breech Types
- Frank (65%): Hips flexed, knees extended (feet near head)
- Complete (10%): Hips/knees flexed (cross-legged)
- Incomplete/Footling (25%): One/both feet presenting — higher cord prolapse risk
External Cephalic Version (ECV)
- Offered at 36-37 weeks if no contraindications
- Success rate: 50-60% (multips higher)
- Reduces cesarean rate significantly
- Risks: Transient FHR changes (5%), abruption (<1%), preterm labor
Planned Cesarean Indications (ACOG/RCOG)
- Footling/incomplete breech
- Estimated fetal weight <2500g or >4000g
- Hyperextended fetal head (ultrasound)
- Contracted pelvis / cephalopelvic disproportion
- Prior uterine surgery (classical incision, myomectomy)
- Placenta previa, vasa previa
- Multiple gestation (breech first twin — controversial)
- Maternal medical contraindications to labor
- No skilled provider for VBD
Criteria for Offering Vaginal Breech Delivery
- Frank or complete breech
- EFW 2500-4000g
- Flexed head (chin tucked; ultrasound)
- Adequate pelvis (clinical pelvimetry or imaging)
- No contraindications to labor
- Experienced provider (documented breech competency)
- Continuous EFM, immediate cesarean capability
- Informed consent: Discuss risks (perinatal mortality 0.5-1% vs 0.1-0.2% for cephalic)
Intrapartum Management (VBD)
- "Hands off the breech" until spontaneous delivery to umbilicus
- Maternal positioning: All fours, kneeling, or lithotomy
- Episiotomy often performed
- Maneuvers if needed: Lovset's (shoulders), Mauriceau-Smellie-Veit (head)
- Piper forceps for aftercoming head (if needed)
- Time limits: Active phase ≤2 hrs; pushing ≤1 hr (nullip), ≤30 min (multip)
Outcomes Comparison
| Outcome | Planned C-Section | VBD (Selected) |
|---|---|---|
| Perinatal mortality | 0.1-0.2% | 0.5-1% |
| Neonatal morbidity | Lower | Slightly higher (birth trauma, asphyxia) |
| Maternal morbidity (short-term) | Higher (surgery risks) | Lower |
| Maternal morbidity (long-term) | Higher (placenta accreta spectrum, adhesions) | Lower |
| Future pregnancy risks | Increased | Baseline |
